Announcements

Three Questions with Sarcopenia 2 Principal Investigators Dr. Shalender Bhasin and Dr. Peggy Cawthon

September 21, 2020 — The FNIH Biomarkers Consortium Sarcopenia 2 project, Sarcopenia as a Valid Biomarker for Identifying Individuals at Risk of Disability, recently achieved the key milestone of publishing seven articles in The Journal of the American Geriatrics Society and The Journals of Gerontology

Read More

The FNIH Earns Coveted Four-Star Rating from Charity Navigator for Sixth Consecutive Year

June 8, 2020  — For the sixth year in a row, the Foundation for the National Institutes of Health (FNIH) has earned the top designation of four-star honors from the nation’s largest independent charity evaluator, Charity Navigator. Only 9 percent of charities evaluated by the group have received this highest rating for at least six consecutive years, indicating that the FNIH “outperforms most charities in America.”

Read More

FNIH Launches Project Testing Antibiotic to Prevent Infections in Mothers and Newborns

June 3, 2020 – The Foundation for the National Institutes of Health (FNIH) has announced a new project that will test whether an antibiotic taken during labor can prevent infections in mothers and newborns in seven low- and middle-income countries. This study will be conducted by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) through their Global Network for Women’s and Children’s Health Research (Global Network) with funding from the Bill & Melinda Gates Foundation.

Read More

FNIH Biomarkers Consortium NIMBLE Project Receives FDA Nod to Move Forward in Biomarker Qualification

May 15, 2020 — The FNIH Biomarkers Consortium program Non-Invasive Biomarkers of Metabolic Liver Disease (NIMBLE) has received acceptance from the U.S. Food and Drug Administration (FDA) for its Letter of Intent (LOI). NIMBLE seeks to qualify biomarkers to easily diagnose clinically significant non-alcoholic steatohepatitis, or NASH.

Read More

FNIH Biomarkers Consortium Launches a Project to Select Blood Tests that Detect Early Alzheimer's Disease

March 12, 2020 — The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has launched a new project under its Neuroscience Steering Committee that will identify the best blood tests to aid in the early detection of Alzheimer’s disease.

Read More

FNIH Biomarkers Consortium Launches ChIIME to Identify Biomarkers that Predict Response to Immunotherapy in Breast Cancer Patients

October 21, 2019 — The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has launched a new project under its Cancer Steering Committee that will identify biological markers (biomarkers) that predict personalized response to immunotherapy after a patient receives chemotherapy. The “Chemotherapeutic Impact on the Immune MicroEnvironment (ChIIME)” project will use a cutting-edge technology called single nucleus RNA sequencing to analyze metastatic breast cancer samples.

Read More

FNIH Biomarkers Consortium Launches Project that will Standardize the Measurement of Genetic Blood Tests to Track Cancer

September 24, 2019 — The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has launched a new project under its Cancer Steering Committee that will standardize the assessment of genetic tests that use blood samples to track cancer in hospitals and laboratories across the United States. In particular, the project will develop tools to enable clinicians to measure and confidently compare circulating tumor DNA (ctDNA) test results across different laboratories.

Read More

FNIH President Dr. Maria Freire Wins NonProfit PRO's "Executive of the Year" Award

BETHESDA, MD, June 13, 2019 — The Foundation for the National Institutes of Health (FNIH) is proud to announce that President and Executive Director Maria C. Freire, Ph.D., has been named “Executive of the Year” by NonProfit PRO.

Read More

FNIH Biomarkers Consortium Launches NIMBLE to Replace Invasive and Painful Biopsy with Non-Invasive Biomarkers for Liver Disease

June 11, 2019 – The FNIH Biomarkers Consortium has launched a new project under its Metabolic Disorders Steering Committee that will standardize biological markers (biomarkers) that help diagnose Non-Alcoholic SteatoHepatitis (NASH) – a type of liver disease. The “Non-Invasive Biomarkers of Metabolic Liver DiseasE (NIMBLE)” project will directly compare imaging and blood-based biomarkers to biopsy results to define the best tools for diagnosing NASH.

Read More

The FNIH Earns Highest Rating From Charity Navigator for the Fifth Consecutive Year

April 23, 2019 - The Foundation for the National Institutes of Health (FNIH) has received top honors again this year from Charity Navigator by earning it’s coveted 4-star rating. Charity Navigator, the nation’s largest independent charity evaluator, has recognized the FNIH with its highest rating for demonstrating strong financial health and commitment to accountability and transparency.

Read More